1,534 reports of this reaction
6.0% of all PHENOBARBITAL reports
#2 most reported adverse reaction
SEIZURE is the #2 most commonly reported adverse reaction for PHENOBARBITAL, manufactured by Chartwell Governmental & Specialty RX, LLC.. There are 1,534 FDA adverse event reports linking PHENOBARBITAL to SEIZURE. This represents approximately 6.0% of all 25,712 adverse event reports for this drug.
Patients taking PHENOBARBITAL who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is moderately reported among PHENOBARBITAL users, representing a notable but not dominant share of adverse events.
In addition to seizure, the following adverse reactions have been reported for PHENOBARBITAL:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 1,534 FDA reports for PHENOBARBITAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 6.0% of all adverse event reports for PHENOBARBITAL, making it one of the most commonly reported side effect.
If you experience seizure while taking PHENOBARBITAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.